Complement Component C4
The complement system is a group of soluble and cell-surface proteins whose function is to recognize, opsonize (label), and alter host cells to destroy and clear invading microorganisms and cancer cells (e.g., apoptotic or necrotic cells). Complement is a major part of the innate immune system and can be activated via the classical and the alternative route. There are about 35 complement proteins. Complement factor C4, which is one of the major complement proteins, participates in activation of the classical route of complement activation. Therefore, if C4 levels decrease it would directly impact the ability of the immune system to fight and clear infectious and cancerous pathogens. A decrease in C4 is common, but complete absence is rare. A lowered concentration or the complete absence of C4 is seen in immune complex diseases, systemic lupus erythematosus (SLE), autoimmune thyroiditis, and juvenile dermatomyositis. Early detection of C4 deficiency in SLE patients can be helpful in early treatment and management of disease. In addition, decreased levels are also seen in liver disease where the synthesis of these proteins is impaired, as well as in burns where protein loss cannot be compensated. Decreased C4 plasma levels are also seen in infections such as bacterial and viral meningitis, streptococcal and staphylococcal sepsis. Increased levels are seen in infections, inflammation, and various malignancies where the body is trying to clear infected or cancerous cells. Testing for C4 complement component is mainly used for assessing the course of hypocomplement conditions.
- As an aid in diagnosis of recurrent microbial infections (viral meningitis, bacterial sepsis)
- As an aid in diagnosis and monitoring the activity of acute or chronic autoimmune diseases such as systemic lupus erythematosus (SLE), rheumatoid arthritis, serum sickness, thyroiditis, and juvenile dermatomyositis
- Diagnosis of Complement Component C4 congenital deficiency and other complement deficiencies
Increased in:
- Various malignancies (not clinically useful)
- Infections
- Inflammations
Decreased by:
- Autoimmune disorders such as SLE
- Rheumatoid arthritis
- Proliferative glomerulonephritis
- Hereditary angioedema
- Decreased synthesis (e.g., congenital deficiency) and increased loss such as burns and protein-losing enteropathies
| Age Group | mg/dL | mg/L |
| Cord Serum | 13.7-44.9 | 137-449 |
| 1mo | 27.5-47.3 | 275-473 |
| 6m | 30.5-58.7 | 305-587 |
| Adults | 28.7-67.5 | 287-675 |
Serum (SST).
Stability
- Ambient: 72 hours
- Refrigerated: 7 days
- Frozen: 30 days
- Serum should be separated immediately from clot. Overnight fasting preferred.
- Ann N Y Acad Sci. 2009 Sep;1173:108-23. [PMID: 19758139]
- Ann Med Interne (Paris). 2003 Dec;154(8):529-40. [PMID: 15037829]
- Biochem Soc Trans. 2004 Feb;32(Pt 1):21-7. [PMID: 14748705]
- N Engl J Med. 1987;316:1525. [PMID: 3295544]
- Intern Med. 2001;40:1254. [PMID: 11813855]
- Curr Rheumatol. Rep 2004;6:375. [PMID: 15355750]
- Curr Opin Pediatr. 1998 Dec;10(6):600-6. [PMID: 9848020]
- Pediatr Clin North Am. 2000 Dec;47(6):1339-54. [PMID: 11130999]
- J Allergy Clin Immunol. 2004 Apr;113(4):585-93. [PMID: 15100659]
- Alan Wu. Tietz Clinical Guide to Laboratory Tests, Fourth Edition. Saunders; 4 edition (June 13, 2006). ISBN-10: 0721679757